4/8/2010 | CVPF | NexMed files $30 million shelf for convertibles, preferreds, stock
|
3/17/2010 | PP | New Issue: NexMed completes $4 million private placement of 7% convertible notes
|
3/17/2010 | PP | Market Commentary: Dynasty ups issue to C$15 million; Energizer closes sale; Breakwater wants exploration funding
|
1/28/2010 | PP | New Issue: NexMed concludes $2.2 million placement of unsecured promissory notes
|
7/1/2008 | PP | New Issue: NexMed wraps $5.75 million convertible notes sale
|
7/1/2008 | PP | Market Commentary: NexMed secures $5.75 million bridge financing; Consumer Portfolio, Simtrol, PuriCore boost capital
|
10/31/2007 | PP | New Issue: NexMed closes $3 million placement of note, warrants
|
12/22/2006 | PP | Market Commentary: Columbia Labs pockets $40 million from convertibles; World Heart stock jumps on PIPE
|
12/21/2006 | PP | New Issue: NexMed pockets $8.66 million from private placement of stock
|
12/21/2006 | PP | Market Commentary: Force Protection pockets $152.75 million from stock offering; NexMed raises $8.65 million from PIPE
|
12/4/2006 | PP | New Issue: NexMed wraps $2 million private placement of notes with warrants
|
8/24/2006 | BT | NexMed expects $2 million milestone payment by year end, preparing to file NDA for Alprox-TD in '07
|
8/3/2006 | BT | NexMed maintains Nasdaq listing
|
7/12/2006 | BT | NexMed: 37 patent claims allowed for Alprox-TD for erectile dysfunction; Nasdaq hearing set
|
7/3/2006 | BT | NexMed to appeal Nasdaq delisting
|
6/26/2006 | BT | NexMed: Schering AG terminates its license for Alprox-TD for erectile dysfunction
|
6/1/2006 | BT | NexMed receives Nasdaq delisting warning letter
|
5/10/2006 | BT | Nexmed lays off 40% of staff, plans to renegotiate notes due in 2006
|
5/9/2006 | BT | NexMed reports first-quarter net loss; out of Nasdaq compliance
|
3/17/2006 | BT | NexMed surge in 2005 revenue may not guarantee continuation as going concern
|
3/17/2006 | BT | Market Commentary: Sunesis stock leaps 11.4% on $45 million PIPE; Salix's stock drops on FDA approval of OsmoPrep
|
2/7/2006 | BT | NexMed maintains Nasdaq listing
|
1/25/2006 | PP | Market Commentary: NitroMed will pocket $62.53 million from direct stock deal; NexMed wraps $8.32 million PIPE
|
1/25/2006 | BTPP | New Issue: NexMed settles $8.32 million private placement of shares
|
1/6/2006 | BT | Nasdaq warns NexMed that it doesn't comply with listing requirements
|
12/15/2005 | BT | NexMed cuts workforce by 26%, CEO departs
|
9/15/2005 | BT | NexMed to receive $4 million initial payment, up to $51 million total under Novartis licensing deal
|
9/15/2005 | BT | Market Commentary: Myogen, Geron follow-ons at bat; ViroPharma up; Advancis almost doubles; GTx launches new deal
|
6/16/2005 | BT | Insamed upgraded by CE Unterberg
|
5/18/2005 | PP | New Issue: NexMed arranges $4.45 million private placement of preferred stock
|
5/18/2005 | PP | Market Commentary: B + H Ocean Carriers raises $60 million; private placement volume improves
|
12/22/2004 | PP | New Issue: NexMed raises $7 million in private placement of shares
|
12/22/2004 | PP | Market Commentary: Private placement volume sluggish despite higher stocks; Loudeye wraps $25.2 million deal
|